<DOC>
	<DOCNO>NCT01855620</DOCNO>
	<brief_summary>Two-thirds young woman United States overweight obese . This excess weight may affect body metabolize drug different birth control method . There lot research excess weight could affect hormone level contraceptive implant . Methods like implant contain progesterone , hormone increase woman 's risk blood clot . These method would prefer overweight obese woman excess weight also increase woman 's risk blood clot . The investigator propose study compare blood hormone level woman use implant least twelve month weight category . The investigator hope show woman , regardless weight , hormone level high enough prevent pregnancy .</brief_summary>
	<brief_title>The Effect Body Mass Index Etonogestrel Hormone Levels Women Using Single-rod Contraceptive Implant</brief_title>
	<detailed_description>Two-thirds reproductive-age woman United States either overweight obese . Body composition may affect contraceptive hormone metabolism possibly efficacy . Phase III study date include woman weigh 70 kilogram ( 134 923 , 14.5 % ) ; report pregnancy group . Data pregnancy rate woman higher body mass index ( BMI ) categories use etonogestrel implant exists , know little weight affect serum etonogestrel level . Progestin-only method , etonogestrel implant , may prefer combined method include estrogens obesity increase thrombosis risk . The investigator propose prospective study compare serum etonogestrel level second third year implant use woman across body mass index category . Based previous study , investigator expect difference etonogestrel level base body weight ; however , investigator hypothesize etonogestrel level remain threshold ovulation suppression three year implant use woman across BMI category . The investigator measure serum level etonogestrel normal weight ( BMI &lt; 25kg/m2 ) , overweight ( BMI ≥ 25kg/m2 &lt; 30kg/m2 ) , obese woman ( BMI ≥ 30kg/m2 ) use single-rod contraceptive implant least twelve month . Their primary objective compare three group evaluate whether etonogestrel level fall critical level contraceptive efficacy ( 90 pg/mL ) ( Díaz 1991 ) group .</detailed_description>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<criteria>Woman use contraceptive implant 12 month English Spanishspeaking</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Contraception</keyword>
	<keyword>Implant</keyword>
	<keyword>Obesity</keyword>
</DOC>